Lv5
1000 积分 2021-10-02 加入
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
2个月前
已完结
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
2个月前
已完结
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
2个月前
已完结
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
2个月前
已完结
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
2个月前
已完结
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已关闭
The pathogenesis of psoriatic arthritis
2个月前
已完结
Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy
2个月前
已完结
Combining information from multiple bone turnover markers as diagnostic indices for osteoporosis using support vector machines
2个月前
已完结
Combining information from multiple bone turnover markers as diagnostic indices for osteoporosis using support vector machines
2个月前
已完结
皖公网安备34019202002308
